Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro drug susceptibility of Chlamydia sp. strain TWAR.

Literature DB >> 2966609

In vitro drug susceptibility of Chlamydia sp. strain TWAR.

Abstract

The in vitro susceptibilities of eight Chlamydia sp. strain TWAR isolates were tested against tetracycline, erythromycin, penicillin, ampicillin, sulfisoxazole, and a new drug, trospectomycin. The ranges of inhibitory concentrations of these antimicrobial agents, except for sulfonamide, were similar to those for Chlamydia trachomatis. Sulfisoxazole was not inhibitory at the highest nontoxic concentration tested.

Entities: Chemical Species

Mesh：

Substances：

Year: 1988 PMID： 2966609 PMCID： PMC172146 DOI： 10.1128/AAC.32.2.257

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

8 in total

1. Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization.

Authors: L A Campbell; C C Kuo; J T Grayston
Journal: J Clin Microbiol Date: 1987-10 Impact factor: 5.948

2. In vitro assays of the efficacy of antimicrobial agents in controlling Chlamydia trachomatis propagation.

Authors: C K Lee; W R Bowie; E R Alexander
Journal: Antimicrob Agents Chemother Date: 1978-03 Impact factor: 5.191

3. Identification of a new group of Chlamydia psittaci strains called TWAR.

Authors: C C Kuo; H H Chen; S P Wang; J T Grayston
Journal: J Clin Microbiol Date: 1986-12 Impact factor: 5.948

4. Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture.

Authors: C C Kuo; S P Wang; J T Grayston
Journal: Antimicrob Agents Chemother Date: 1977-07 Impact factor: 5.191

5. Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR.

Authors: E Y Chi; C C Kuo; J T Grayston
Journal: J Bacteriol Date: 1987-08 Impact factor: 3.490

6. Pneumonia associated with the TWAR strain of Chlamydia.

Authors: T J Marrie; J T Grayston; S P Wang; C C Kuo
Journal: Ann Intern Med Date: 1987-04 Impact factor: 25.391

7. Sensitivity of immunofluorescence with monoclonal antibodies for detection of Chlamydia trachomatis inclusions in cell culture.

Authors: R S Stephens; C C Kuo; M R Tam
Journal: J Clin Microbiol Date: 1982-07 Impact factor: 5.948

8. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.

Authors: J T Grayston; C C Kuo; S P Wang; J Altman
Journal: N Engl J Med Date: 1986-07-17 Impact factor: 91.245

8 in total

23 in total

1. Antibiotic susceptibilities of Parachlamydia acanthamoeba in amoebae.

Authors: M Maurin; A Bryskier; D Raoult
Journal: Antimicrob Agents Chemother Date: 2002-09 Impact factor: 5.191

2. In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).

Authors: K Chirgwin; P M Roblin; M R Hammerschlag
Journal: Antimicrob Agents Chemother Date: 1989-09 Impact factor: 5.191

3. In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp.

Authors: N Miyashita; Y Niki; T Kishimoto; M Nakajima; T Matsushima
Journal: Antimicrob Agents Chemother Date: 1997-06 Impact factor: 5.191

4. In vitro activities of lomefloxacin, tetracycline, penicillin, spectinomycin, and ceftriaxone against Neisseria gonorrhoeae and Chlamydia trachomatis.

Authors: H Talbot; B Romanowski
Journal: Antimicrob Agents Chemother Date: 1989-12 Impact factor: 5.191

In vitro drug susceptibility of Chlamydia sp. strain TWAR.

1. Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization.

2. In vitro assays of the efficacy of antimicrobial agents in controlling Chlamydia trachomatis propagation.

3. Identification of a new group of Chlamydia psittaci strains called TWAR.

4. Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture.

5. Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR.

6. Pneumonia associated with the TWAR strain of Chlamydia.

7. Sensitivity of immunofluorescence with monoclonal antibodies for detection of Chlamydia trachomatis inclusions in cell culture.

8. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.

1. Antibiotic susceptibilities of Parachlamydia acanthamoeba in amoebae.

2. In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).

3. In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp.

4. In vitro activities of lomefloxacin, tetracycline, penicillin, spectinomycin, and ceftriaxone against Neisseria gonorrhoeae and Chlamydia trachomatis.

Review 5. Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae.

6. Protective effects of sparfloxacin in experimental pneumonia caused by Chlamydia pneumoniae in leukopenic mice.

7. Chlamydia pneumoniae community-acquired pneumonia: a review of 62 hospitalized adult patients.

8. In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents.

9. Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J mice.

10. Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis.